tiprankstipranks
Advertisement
Advertisement
Cipla approves FY26 results and recommends INR 13 final dividend
PremiumCompany AnnouncementsCipla approves FY26 results and recommends INR 13 final dividend
1M ago
Cipla Clears FY26 Results, Proposes Rs 13 Final Dividend Per Share
Premium
Company Announcements
Cipla Clears FY26 Results, Proposes Rs 13 Final Dividend Per Share
1M ago
Cipla Board Clears FY26 Results and Recommends Final Dividend
Premium
Company Announcements
Cipla Board Clears FY26 Results and Recommends Final Dividend
1M ago
Cipla Issues 1,954 Shares Under Employee Stock Schemes
PremiumCompany AnnouncementsCipla Issues 1,954 Shares Under Employee Stock Schemes
3M ago
Cipla USA Recalls Lanreotide Injection, Causing Temporary Supply Disruption
Premium
Company Announcements
Cipla USA Recalls Lanreotide Injection, Causing Temporary Supply Disruption
3M ago
Cipla Seeks Shareholder Nod for New Global CEO and Board Changes via Postal Ballot
Premium
Company Announcements
Cipla Seeks Shareholder Nod for New Global CEO and Board Changes via Postal Ballot
4M ago
Cipla Warns of Temporary Lanreotide Supply Disruption After USFDA Observations at Supplier
PremiumCompany AnnouncementsCipla Warns of Temporary Lanreotide Supply Disruption After USFDA Observations at Supplier
5M ago
Lilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?
Premium
Market News
Lilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?
6M ago
Cipla Ltd Receives ESG Rating of 66 for FY 2024-25
Premium
Company Announcements
Cipla Ltd Receives ESG Rating of 66 for FY 2024-25
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100